HCA HCA Healthcare Inc

HCA to Present at February Healthcare Conferences

NASHVILLE, Tenn.--(BUSINESS WIRE)--

HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences in February 2018.

February 15, 2018 at 11:30 am (EST) at the LEERINK Partners 7th Annual Global Healthcare Conference held at the Lotte New York Palace, New York, NY.

February 22, 2018 at 8:30 am (EST) at the RBC Capital Markets 2018 Global Healthcare Conference held at Lotte New York Palace, New York, NY.

A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.

Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.

All references to “Company” and “HCA” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.

EN
26/01/2018

Underlying

HCAHCA Healthcare Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HCA Healthcare Inc

Free Trial
HCA HCA Healthcare ...

HCA Healthcare Inc: 2 directors

Two Directors at HCA Healthcare Inc sold/sold after exercising options 12,020 shares at between 505.000USD and 514.582USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by al...

HCA HCA HEALTHCARE INC
02/13/26 February 13, 2026 1 EN
HCA HCA Healthcare ...

HCA Healthcare, Inc. - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

HCA HCA HEALTHCARE INC
12/03/25 December 3, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.07
SLB.N SCHLUMBERGER NV
TSLA TESLA INC ... (+17)

Vermilion Compass: Weekly Equity Strategy

Magnificent Seven's Turn to Shine We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and the S&P 500 (SPX) is above 6200 (up from 6028-6059). Additionally, we discussed since our 10/14/25 Compass how our near-term bullish outlook remains intact as long as the SPX holds above 6550-6569, which coincided with the ...

SLB.N SCHLUMBERGER NV
TSLA TESLA INC
THC TENET HEALTHCARE CORPORATION
NVDA NVIDIA CORPORATION
HCA HCA HEALTHCARE INC
HAL HALLIBURTON COMPANY
GOOGL ALPHABET INC. CLASS A
CYH COMMUNITY HEALTH SYSTEMS INC.
MAGS MAGAL SECURITY SYSTEMS LTD.
RIGN TRANSOCEAN LTD.
AAPL APPLE INC.
SDRL SEADRILL LTD.
VAL VALARIS LTD
BORR BORR DRILLING LTD
ARKK ARK INNOVATION ETF
NE NOBLE CORP (NEW)
ARDT ARDENT HEALTH PARTNERS INC
11/04/25 November 4, 2025 1 EN
HCA HCA Healthcare ...

HCA Inc.: Update to credit analysis following upgrade to Baa2

Our credit view of this issuer reflects its significant scale and strong free cash flow, offset by its history of shareholder-friendly policies.

HCA HCA HEALTHCARE INC
10/28/25 October 28, 2025 1 EN
HCA HCA Healthcare ...

Moody's Ratings assigns Baa2 rating to HCA's proposed senior unsecured...

Moody's Ratings (Moody's) assigned Baa2 ratings to HCA Inc.'s ("HCA") proposed offering of backed senior unsecured notes of up to $3.25 billion with various maturities. HCA intends to use the net proceeds from this offering for general corporate purposes including repayment of outstanding borrowings...

HCA HCA HEALTHCARE INC
10/27/25 October 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch